An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes. Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital that he’s been able to walk again after an … Read more
Ryan Baldridge Jr. was a bright, talkative toddler — breezing through flash cards, building an “astonishing” vocabulary and hitting developmental milestone with ease. Then, at 18 months, something shifted. “It was like he was erased and reset,” his father, Ryan Baldridge Sr., told The Post. “Everything changed.” Suddenly, the young boy, known to his family … Read more
A novel gene therapy has been found to significantly slow the progression of Huntington’s disease, offering new hope to sufferers of the incurable disorder that destroys brain cells over time. Drugmaker uniQure reported the results of its small but “groundbreaking” Phase I/II study this week, finding that a high dose of its AMT-130 therapy slowed … Read more
Needle-less to say, it’s effective! Eli Lilly’s experimental GLP-1 pill caused participants in a late-stage trial to shed an average of 10.5% of their body weight — nearly 23 pounds — over 16 months, according to data released Tuesday. The daily medication, known as orforglipron, has also been shown to reduce hemoglobin A1C —average blood … Read more
Life’s ruff enough without the added challenge of getting your pudgy pup or tubby tabby to slim down. America’s obesity crisis extends beyond humans — studies suggest that around 60% of dogs and cats nationwide are overweight. The consequences are far from fluffy. Those extra pounds can lead to serious health issues, sky-high vet bills … Read more
An eight-year-old boy has regained his ability to walk with the aid of a compound found in a common over-the-counter supplement. The boy’s case was detailed in the journal Nature. The unnamed child was an active athlete until the summer of 2023, when he began to struggle with mobility. Within months, his symptoms progressed to the … Read more
Sit, stay… live longer? Research shows that owning a dog can help humans live longer, healthier lives. Now, a US biotech company wants to return the favor with anti-aging drugs designed to extend the lifespan of your canine companion. “The longevity space is crowded right now, and for good reason,” Celine Halioua, founder and CEO … Read more
A real ache-ievement! Duke University researchers have devised a promising, potent pain reliever — seemingly without the harmful side effects and addictive highs of opioids. While opioids interact with numerous cellular pathways, the experimental drug is more selective. SBI-810 targets a receptor in the brain and spinal cord, activating a single pain-relief signal while steering … Read more
A new once-daily pill may raise the bar for weight loss meds. Ozempic, Mounjaro and similar drugs that mimic the GLP-1 hormone the body naturally produces after eating can cause significant weight loss, but a potential side effect is loss of lean muscle mass. The makers of the experimental drug SYNT-101 claim it mimics the … Read more
Chronic lower back pain is one of the top complaints that sends Americans to their doctors — and it’s a leading cause of missed workdays and disability claims. While slipped discs, arthritis and spinal problems are often blamed, for some, the real culprit is an infection. Now, there’s hope on the horizon for these patients. … Read more
As scientists continue to investigate the roots of autism, a generic cancer drug might hold the key. Leucovorin is prescribed to reduce the side effects of chemo. But in several studies conducted over the past 13 years, Dr. Richard Frye has compiled growing evidence that it can improve signs of autism, even leading nonverbal children … Read more
A Mississippi high school football coach has finally reached the end zone of his cancer fight thanks to a peculiar, experimental treatment. Tim Story was diagnosed at 49 with stage 3 small bowel cancer after noticing strange pain in his sides. Two years and several challenging rounds of chemotherapy later, the Hattiesburg resident was told … Read more
Researchers say they have sparked an “exciting” breakthrough in treating Alzheimer’s disease by developing a drug to prevent the build-up of toxic proteins in the brain. “This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the brains of people living with Alzheimer’s, preventing it from clumping … Read more
A miracle UK baby who was born four months early, weighing the same as a loaf of bread, has beaten incredible odds to celebrate his first birthday. Arley-James Hughes was so small that he had to be kept in a “sandwich bag” shortly after birth to mimic being inside his mom’s womb. Entering the world … Read more
Want to lose weight and get fit? It could soon be as easy as sitting on the couch and stuffing your face with your favorite food. US pharmacy researchers have developed and tested a new drug that could help humans lose weight simply by convincing the body’s muscles that they are exercising. The drug — … Read more